Kite Pharma Competitors and Similar CompaniesClear all
Kite Pharma's competitors and similar companies include G1 Therapeutics, Amgen, Novartis, Juno Therapeutics and Adaptive Biotechnologies.
 G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. |  Adaptive Biotechnologies Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease. | ||
Founding Date | Founding Date 2009 | Founding Date 2008 | Founding Date 1980 | Founding Date 1996 | Founding Date 2013 | Founding Date 2009 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||||
Locations | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations Durham, US HQ | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US | Locations Seattle, US HQ New York, US South San Francisco, US |
Employees | Employees 3,9671% decrease | Employees 17015% increase | Employees 25,200 | Employees 75,883 | Employees 1091% decrease | Employees 70910% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 377.2 m | Valuation ($) 170.4 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 694.6 m |
Financial | ||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $82.5m (FY, 2023) | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $111.9m (FY, 2017) | Revenue (est.) $277m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $7.2m (FY, 2023) | Cost of goods $12b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods N/A | Cost of goods $71.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $75.3m (FY, 2023) | Gross profit $24.7b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit N/A | Gross profit $205.6m (FY, 2025) |
Net income | Net income N/A | Net income ($48m) (FY, 2023) | Net income $7.7b (FY, 2025) | Net income $14b (FY, 2025) | Net income ($437.1m) (FY, 2017) | Net income ($59.5m) (FY, 2025) |
Operating ⚠ | ||||||
Patents (US) | Patents (US) N/A | Patents (US) 40 (FY, 2020) | Patents (US) 31 (FY, 2020) | Patents (US) N/A | Patents (US) 72 (FY, 2016) | Patents (US) N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products N/A | Phase III Trials Products N/A |
Funding | ||||||
Total funding raised | Total funding raised $ 85.3m | Total funding raised $ 289.6m | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised $ 310m | Total funding raised $ 525m |
For sources of this data, please see the company profile
View Company Profiles
G1 Therapeutics
HQ
Durham, US
Employees
170↑ 15% increase
G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
View companyAmgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyJuno Therapeutics
HQ
Seattle, US
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company